Recruiting PHASE2 Dry Eye

New treatment option for Dry Eye

Official title Evaluation of BTV100 in Subjects With Dry Eye Disease

ClinicalTrials.gov ID: NCT06543303

What this study is testing

What is BTV100 Low dose?

BTV100 Low dose is an investigational medicine, given as an once-daily treatment applied to the skin, being studied as a potential treatment for dry eye.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
This study will be a randomized, vehicle-controlled, double-masked, multiple-dose, parallel-group study to evaluate the efficacy, safety and tolerability of repeat dosing of Cevimeline Ophthalmic Solution compared to the vehicle in subjects with Dry Eye Disease (DED).
  • Phase 2: a mid-size study of how well it works
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • 18 years of age or older (regardless of gender).
  • Provide written informed consent.
  • Willing and able to follow instructions and be available for required study visits during the study.
  • Best Corrected Visual Acuity (BCVA) of 20/100 or better in both eyes.
  • Ongoing moderate to severe Dry Eye Disease (DED) supported by a previous clinical diagnosis or a self-reported history of subjective complaints for...

You likely can't join if

  • Known hypersensitivity or contraindication to the study drug or its components.
  • Within 28 days prior to the screening visit (Visit 1), have taken or used: Topical ophthalmic, dermatologic or systemic calcineurin inhibitor (e.g...
  • Current use of contact lenses or anticipated use during the study.

The study team makes the final eligibility decision.

Where it's taking place

  • Doncaster East, Victoria, Australia
  • Sydney, Australia
  • Kaohsiung City, Taiwan
  • Taipei, Taiwan
  • Taoyuan, Taiwan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Doncaster East, Victoria, Australia; Sydney, Australia; Kaohsiung City, Taiwan; Taipei, Taiwan; Taoyuan, Taiwan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.